These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8783384)

  • 1. In vivo apparent pA2 analysis in rats treated with either clocinnamox or morphine.
    Walker EA; Richardson TM; Young AM
    Psychopharmacology (Berl); 1996 May; 125(2):113-9. PubMed ID: 8783384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clocinnamox distinguishes opioid agonists according to relative efficacy in normal and morphine-treated rats trained to discriminate morphine.
    Walker EA; Young AM
    J Pharmacol Exp Ther; 2002 Jul; 302(1):101-10. PubMed ID: 12065706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats.
    Walker EA; Makhay MM; House JD; Young AM
    J Pharmacol Exp Ther; 1994 Nov; 271(2):959-68. PubMed ID: 7965818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the irreversible mu-opioid receptor antagonist clocinnamox on morphine potency, receptor binding and receptor mRNA.
    Chan K; Brodsky M; Davis T; Franklin S; Inturrisi CE; Yoburn BC
    Eur J Pharmacol; 1995 Dec; 287(2):135-43. PubMed ID: 8749027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids.
    Zhang L; Walker EA; Sutherland J; Young AM
    Psychopharmacology (Berl); 2000 Feb; 148(2):136-45. PubMed ID: 10663428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of irreversible antagonists to determine the relative efficacy of mu-opioids in a pigeon drug discrimination procedure: comparison of beta-funaltrexamine and clocinnamox.
    Barrett AC; Smith ES; Picker MJ
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1061-70. PubMed ID: 12649297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clocinnamox inhibits the intravenous self-administration of opioid agonists in rhesus monkeys: comparison with effects on opioid agonist-mediated antinociception.
    Zernig G; Lewis JW; Woods JH
    Psychopharmacology (Berl); 1997 Feb; 129(3):233-42. PubMed ID: 9084061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox.
    Zernig G; Butelman ER; Lewis JW; Walker EA; Woods JH
    J Pharmacol Exp Ther; 1994 Apr; 269(1):57-65. PubMed ID: 8169852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice.
    Burke TF; Woods JH; Lewis JW; Medzihradsky F
    J Pharmacol Exp Ther; 1994 Nov; 271(2):715-21. PubMed ID: 7965787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clocinnamox dose-dependently antagonizes morphine-analgesia and [3H]DAMGO binding in rats.
    Paronis CA; Woods JH
    Eur J Pharmacol; 1997 Oct; 337(1):27-34. PubMed ID: 9389377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnitude of tolerance to fentanyl is independent of mu-opioid receptor density.
    Chan KW; Duttory A; Yoburn BC
    Eur J Pharmacol; 1997 Jan; 319(2-3):225-8. PubMed ID: 9042594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine.
    Walker EA; Young AM
    J Pharmacol Exp Ther; 1993 Oct; 267(1):322-30. PubMed ID: 8229759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus effects of morphine: effects of training dose on agonist and antagonist effects of mu opioids.
    Young AM; Masaki MA; Geula C
    J Pharmacol Exp Ther; 1992 Apr; 261(1):246-57. PubMed ID: 1560372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
    Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. kappa-Opioid receptor effects of butorphanol in rhesus monkeys.
    Vivian JA; DeYoung MB; Sumpter TL; Traynor JR; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1999 Jul; 290(1):259-65. PubMed ID: 10381785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clocinnamox antagonism of opioid suppression of schedule-controlled responding in rhesus monkeys.
    Butelman ER; Negus SS; Lewis JW; Woods JH
    Psychopharmacology (Berl); 1996 Feb; 123(4):320-4. PubMed ID: 8867870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys.
    Ko MC; Butelman ER; Traynor JR; Woods JH
    J Pharmacol Exp Ther; 1998 May; 285(2):518-26. PubMed ID: 9580592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clocinnamox: a novel, systemically-active, irreversible opioid antagonist.
    Comer SD; Burke TF; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1051-6. PubMed ID: 1326622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-choice discrimination in pigeons is based on relative efficacy differences among opioids.
    Walker EA; Picker MJ; Dykstra LA
    Psychopharmacology (Berl); 2001 Jun; 155(4):389-96. PubMed ID: 11441428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of gonadectomy on discriminative stimulus effects of morphine in female versus male rats.
    Craft RM; Heideman LM; Bartok RE
    Drug Alcohol Depend; 1999 Jan; 53(2):95-109. PubMed ID: 10080036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.